The Marcus (MCS) Q4 2014 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2014 earnings summary
9 Nov, 2026Executive summary
F2014 revenue rose 8.5% to $447.9M, operating income increased 26.6% to $48.4M, and net earnings attributable to shareholders reached $25.0M vs. $17.5M. Diluted EPS was $0.92 vs. $0.63.
Growth reflected improved theatre attendance and higher hotel occupancy and room rates; net earnings also benefited from a $4.1M loss allocated to noncontrolling interests, including a settlement-related reallocation.
Financial highlights
Theatre revenue increased 10.8% to $243.2M; hotels and resorts revenue increased 5.9% to $204.1M. Consolidated operating income was $48.4M, up from $38.2M.
Net cash from operations was $66.4M, up 5.1%; capital expenditures were $56.7M vs. $22.6M, and cash used in investing activities was $57.7M.
Reported results included a $4.1M loss attributable to noncontrolling interests, which increased earnings attributable to shareholders; the Skirvin settlement impact was estimated at ~$0.08 per diluted share after tax.
Interest expense was $10.1M, up 8.1%; income tax expense was $16.8M, with an adjusted effective tax rate of 40.2% vs. 39.3%.
Outlook and guidance
FY2015 total capital expenditures were projected at $70M-$90M, excluding unidentified acquisitions; theatre spending was estimated at $45M-$60M and hotels and resorts at $25M-$30M.
Theatre plans included opening the 12-screen Palace at Sun Prairie in February 2015; summer 2014 box office was below the prior year on a weaker film slate, while attendance continued to outperform the industry.
Fiscal 2015 theatre ticket-price and concession-spend comparisons were expected to decline at similar rates in H1; planned film and alternate-content volume was similar to F2014, with ~20 digital 3D films scheduled.
FY2015 interest expense was expected to remain broadly stable; the effective tax rate was expected near 39%-40%, excluding changes in tax positions or rates.
Hotel performance was expected to benefit from completed Pfister and Cornhusker renovations, while the Chicago hotel conversion and added room supply in Milwaukee and Oklahoma City posed near-term headwinds.
Latest events from The Marcus
- FY2023 rebounded across theatres and hotels, while film supply clouds the FY2024 theatre outlook.MCS
Q4 2023 - FY22 recovery lifted EBITDA, but film supply and business travel remain constraints.MCS
Q4 2022 - Recovery lifted FY2021 Adjusted EBITDA to $35.1M, but the net loss remained $43.3M.MCS
Q4 2021 - Pandemic closures drove a $124.8M loss, with recovery hinging on reopening and demand.MCS
Q4 2020 - Record revenue, lower earnings, and COVID-19 closures reshaped the outlook.MCS
Q4 2019 - Record revenue and operating income; Movie Tavern expands the footprint as FY2019 investment rises.MCS
Q4 2018 - Record earnings and theatre outperformance powered growth amid acquisition-led expansion.MCS
Q4 2016 - Record FY2017 results, boosted by theatre growth and a one-time tax benefit.MCS
Q4 2017 - Record revenue and segment growth; adjusted earnings rose nearly 12%.MCS
Q4 2015